Original BioMedicals Co., Ltd. is a biotechnology company focused on creating novel chemical compounds to fulfill critical medical requirements, with an initial emphasis on the healthcare landscape in Taiwan. Its current product pipeline encompasses several key developments: Radprotect (A01): A pre-clinical stage compound designed to offer protection against radiation exposure. CCM-Ami (A02): Engineered to shield healthy tissues from the damaging side effects of both chemotherapy drugs and ionizing radiation. GLP-1 CCM (P01): A therapeutic agent developed for the management of type 2 diabetes. The firm was established in 2011 and operates from its base in Taipei, Taiwan.
常見問題
Original Biomedicals. 今天的股價是多少?▼
6483.TWO 目前價格為 TWD15.80 TWD,過去 24 小時上漲了 +8.22%。在圖表上更密切關注 Original Biomedicals. 股價表現。
Original Biomedicals. 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Taiwan OTC Exchange 交易所,Original Biomedicals. 的股票以代號 6483.TWO 進行交易。
Original Biomedicals. 的股價在上漲嗎?▼
6483.TWO 股票較上週上漲 +13.26%,本月上漲 +20.15%,過去一年 Original Biomedicals. 上漲 +45.62%。
Original Biomedicals. 的市值是多少?▼
今天 Original Biomedicals. 的市值為 1.05B
Original Biomedicals. 去年的營收是多少?▼
Original Biomedicals. 去年的營收為 381,000TWD。
Original Biomedicals. 去年的淨利是多少?▼
6483.TWO 去年的淨收益為 -101.51MTWD。
Original Biomedicals. 有多少名員工?▼
截至 2026年11月2日,公司共有 25 名員工。
Original Biomedicals. 位於哪個產業?▼
Original Biomedicals.從事於Health & Wellness產業。
Original Biomedicals. 何時完成拆股?▼
Original Biomedicals. 最近沒有進行任何拆股。
Original Biomedicals. 的總部在哪裡?▼
Original Biomedicals. 的總部位於 台灣 的 Taipei。